High Outlier
DEA Schedule CIV
Strength
8 mg/1
Manufacturer
KVK-Tech Inc.NDC
10702000109
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203495On Market Since
9/12/2016
Pharmacological Classes
Related Drugs
Same classification
NASAL SPRAY 0.05%
Generic
36800030410•Topco Associates LLC
$0.0625
per ML
NASAL SPRAY 0.05%
Generic
36800081710•Topco Associates LLC
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203005•Taro Pharmaceuticals U.S.A. Inc.
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203003•Taro Pharmaceuticals U.S.A. Inc.
$0.0678
per ML
PHENTERMINE 37.5 MG TABLET
Generic
11534016001•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016003•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016030•Sunrise Pharmaceutical Inc.
$0.0694
per EA
GS SINUS NASAL SPRAY 0.05%
Generic
00113081710•L. Perrigo Company
$0.0737
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
00904676130•Major Pharmaceuticals
$0.0737
per ML
GS NASAL SPRAY 0.05%
Generic
00113030410•L. Perrigo Company
$0.0778
per ML